BAYER AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.06 EUR | -0.69% |
|
-3.49% | -22.61% |
| 10:38am | Capgemini: new platform implemented for Bayer | CF |
| 10:16am | TV ratings: Bayer's Europa League success brings RTL many viewers | DP |
| Sales 2024 * | 47.23B 50.34B | Sales 2025 * | 48.12B 51.3B | Capitalization | 25.78B 27.48B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.36B 2.51B | Net income 2025 * | 3.21B 3.42B | EV / Sales 2024 * | 1.24 x |
| Net Debt 2024 * | 32.81B 34.97B | Net Debt 2025 * | 29.7B 31.67B | EV / Sales 2025 * | 1.15 x |
| P/E ratio 2024 * |
11.3
x | P/E ratio 2025 * |
7.96
x | Employees | 96,931 |
| Yield 2024 * |
1.31% | Yield 2025 * |
1.43% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bayer AG
More press releases
More news
| 1 day | -1.09% | ||
| 1 week | -3.69% | ||
| Current month | -8.65% | ||
| 1 month | +0.39% | ||
| 3 months | -19.82% | ||
| 6 months | -38.38% | ||
| Current year | -22.78% |
1 week
25.61
26.86
1 month
25.6128.94
Current year
24.9636.09
1 year
24.9661.48
3 years
24.9667.99
5 years
24.9678.34
10 years
24.96146.45
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
| Director of Finance/CFO | 54 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
| Director/Board Member | 68 | 17-03-31 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 26.02 | -0.84% | 2 787 119 |
| 24-04-18 | 26.24 | -0.04% | 2,759,804 |
| 24-04-17 | 26.25 | +0.65% | 2,359,047 |
| 24-04-16 | 26.08 | -1.44% | 3,296,976 |
| 24-04-15 | 26.46 | -1.87% | 4,111,723 |
Delayed Quote Xetra, April 19, 2024 at 09:13 am EDT
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-04-26
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
26.24
EUR
Average target price
37.05
EUR
Spread / Average Target
+41.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.78% | 27.49B | |
| +27.97% | 672B | |
| +23.66% | 550B | |
| -7.02% | 351B | |
| +14.85% | 317B | |
| +6.25% | 292B | |
| +2.40% | 211B | |
| -0.22% | 203B | |
| -11.81% | 144B | |
| -8.80% | 141B |
- Stock Market
- Equities
- BAYN Stock
